000 01403 a2200385 4500
005 20250511225109.0
264 0 _c19901228
008 199012s 0 0 eng d
022 _a0021-9738
024 7 _a10.1172/JCI114853
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLantz, M
245 0 0 _aCharacterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor.
_h[electronic resource]
260 _bThe Journal of clinical investigation
_cNov 1990
300 _a1396-1402 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aCell Survival
_xdrug effects
650 0 4 _aChromatography, Gel
650 0 4 _aDown-Regulation
650 0 4 _aFibrosarcoma
650 0 4 _aHumans
650 0 4 _aHydrogen-Ion Concentration
650 0 4 _aPrecipitin Tests
650 0 4 _aReceptors, Cell Surface
_xbiosynthesis
650 0 4 _aReceptors, Tumor Necrosis Factor
650 0 4 _aRecombinant Proteins
_xmetabolism
650 0 4 _aSolubility
650 0 4 _aTumor Cells, Cultured
650 0 4 _aTumor Necrosis Factor-alpha
_xmetabolism
700 1 _aGullberg, U
700 1 _aNilsson, E
700 1 _aOlsson, I
773 0 _tThe Journal of clinical investigation
_gvol. 86
_gno. 5
_gp. 1396-1402
856 4 0 _uhttps://doi.org/10.1172/JCI114853
_zAvailable from publisher's website
999 _c2179845
_d2179845